Announcements Trials
Browse Landscape

Status

Completed 946Recruiting 324Terminated 269Unknown 234Active not recruiting 146Withdrawn 91Not yet recruiting 91Suspended 5No longer available 5Enrolling by invitation 3Available 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 7Neuroblastoma 4Recurrence 3Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Insulinoma 2Immunologic Deficiency Syndromes 2Hypoglycemia 2Hyperinsulinism 2Hematologic Neoplasms 2Typical Teratoid Rhabdoid Tumor 1Triple Negative Local Advanced Breast Cancer 1Thyroid Nodule 1Thalassemia 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oncology Patients With Gastroparesis 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Medulloblastoma 1Lymphoma 1

Interventions

Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × OTHER × Multiple Myeloma × Clear all
NCT01250808 2010-12-01

Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy

Peking University

Available
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡